Image

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Testing Amlitelimab for moderate-to-severe eczema in patients 12+.

Recruiting
12 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new treatment, called amlitelimab, for people aged 12 and older with atopic dermatitis (AD) who didn't get better with usual skin creams. AD is a skin condition causing itchy, red, and inflamed skin. The study will compare amlitelimab injections to a placebo, which is like a fake treatment, to see if it helps more than the usual treatment.

The study lasts up to 44 weeks if you don't join a follow-up study, but only 28 weeks if you do. During this time, participants will need to attend up to 10 clinic visits. The main part of the treatment is 24 weeks long.

  • Eligibility: Must be 12 or older, with moderate-to-severe AD.
  • Involves: Up to 10 clinic visits, with options for a follow-up study.
  • Risks: Some people may have side effects; discuss with your doctor.

Participants should be willing to attend all visits and follow study procedures. The study will help determine if this new treatment is safe and effective for people with AD.

Print
Study details
    Dermatitis Atopic

NCT06224348

Sanofi

30 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.